Patients Using GLP-1 Are More than 40 Percent Less Likely to be Hospitalized for Heart Failure

 In the retrospective study, researchers from Henry Ford Hospital in Detroit examined data from more than 4,400 patients taking diabetes medications between 2000 and 2012. About 1,500 were taking GLP-1 medications and nearly 3,000 were not. Over an average 9-month follow-up period, patients taking GLP-1 medications were 41% less likely than others to be hospitalized with heart failure. Additionally, these patients were 44% less likely to be hospitalized for any reason, and 80% less likely to die of any cause. Presented 3-17-2013 at the American College of Cardiology’s annual meeting in San Francisco.